Poster 46 : ENVOL, a Phase 2, open-label trial evaluating the safety and expression of delandistrogene moxeparvovec in Duchenne muscular dystrophy: study design

Mercuri E, Desguerre I, Gangfuss A, Servais L, Nascimento A, Zhang B, Murphy A, Reid C, Wandel C, Singh T, Guridi M, Muntoni F

Neuromuscular disorders : NMD